ArticleNPJ Parkinson's disease2026
Striatal hyperechogenicity as an ultrasound imaging marker for prodromal X-linked dystonia-parkinsonism.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
X-linked dystonia-parkinsonism (XDP) is a neurodegenerative genetic disorder with striatal pathology. We investigated 138 participants (61 patients with XDP, 19 non-manifesting carriers (NMC), and 58 healthy controls (HC)) with transcranial sonography (TCS) to determine the hyperechogenicity of the lentiform nucleus (LN+), the size of the substantia nigra, and the width of the lateral and third ventricles. LN+ was correlated with LN volume as measured by structural T1 imaging. Hexameric repeat number within the causative insertion was determined as a potential modifier. The prevalence of LN+ was higher in patients with XDP (81%) and in NMC (47%) compared to HC (20%). In NMC and XDP with LN+, the estimated age at onset was younger, and the repeat number was higher. There was no difference in the size of the substantia nigra nor in the width of the lateral ventricle. The width of the third ventricle was higher in patients with XDP and correlated with age at examination and disease duration. The MRI-derived LN volume was higher in HC than in NMC and XDP. There were no volume differences between LN+ and LN-. LN+ is observed more frequently in patients with XDP and even several years before symptom onset in NMC, particularly in those with a high genetic modifier burden. TCS might therefore be a helpful tool to identify persons at risk for a more imminent disease manifestation among the NMCs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.